Notable ETF Outflow Detected - IXJ, SYK, DHR, MDT
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 03 2025
0mins
Should l Buy SYK?
Source: NASDAQ.COM
Current Share Price Analysis: IXJ's current share price is $85.32, which is between its 52-week low of $80.681 and high of $101.305, indicating a potential area for technical analysis using the 200-day moving average.
ETFs Trading Dynamics: Exchange traded funds (ETFs) function similarly to stocks, with units that can be created or destroyed based on investor demand, affecting the underlying holdings and market flows significantly.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SYK?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SYK
Wall Street analysts forecast SYK stock price to rise
20 Analyst Rating
17 Buy
3 Hold
0 Sell
Strong Buy
Current: 328.510
Low
390.00
Averages
430.32
High
465.00
Current: 328.510
Low
390.00
Averages
430.32
High
465.00
About SYK
Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Meeting Schedule: Stryker Corporation has scheduled its 2026 Annual Meeting of Shareholders for May 6, 2026, at 12:00 p.m. Eastern Time, to be held virtually, facilitating global shareholder participation.
- Webcast Information: The meeting will be available via webcast, including audio and slide presentations, with details accessible on the company's Investor Relations page, enhancing transparency and shareholder engagement.
- Recording Availability: A recording of the meeting will be available from 10:30 a.m. Eastern Time on May 7, 2026, until the definitive proxy statement for the 2027 Annual Meeting is filed, ensuring shareholders can access the meeting content at their convenience.
- Company Overview: Stryker is a global leader in medical technologies, impacting over 150 million patients annually, and is committed to improving healthcare outcomes through innovative products and services, highlighting its strategic significance in the healthcare sector.
See More
- Partnership Announcement: Microsoft and Accenture have announced a collaboration to enhance cybersecurity solutions using agentic AI, responding to a recent cyberattack on Stryker Corporation that caused global disruptions, highlighting the urgent need for improved security measures.
- Technology Integration: Accenture is expanding its Adaptive MxDR offering to integrate with Microsoft Security platforms, combining multiple security tools such as Sentinel, Defender, and Threat Intelligence to enable faster and more accurate threat detection and response, thereby enhancing corporate security capabilities.
- Automated Responses: The partnership will leverage agentic AI to identify risks, reduce blind spots, and automate routine threat responses, allowing security teams to focus on strategic priorities and improving overall security efficiency.
- Market Reaction: Despite the announcement, MSFT shares have declined over 17% in the past year, while ACN shares have fallen by more than 21%, indicating market concerns and cautious investor sentiment regarding the cybersecurity sector.
See More

- Cyberattack Impact: On March 11, medical device maker Stryker experienced a cyberattack that caused widespread disruption to its computer systems, affecting order processing, product manufacturing, and shipping, highlighting severe cybersecurity vulnerabilities.
- CISA Warning: The Cybersecurity and Infrastructure Security Agency (CISA) reported awareness of malicious cyber activity targeting endpoint management systems of U.S. organizations, emphasizing the urgency of strengthening security configurations.
- Security Recommendations: CISA urged companies to harden endpoint management system configurations by implementing Microsoft's best practices, particularly for Microsoft Intune, to secure user access, devices, and applications, thereby reducing potential risks.
- Coordinated Response Actions: CISA is enhancing coordination with federal partners, including the FBI, to identify additional threats and determine mitigation actions, aiming to improve overall cybersecurity defenses.
See More
- Cyberattack Impact: Stryker (SYK) faced a significant cyberattack last week that disrupted its global business networks, with the attackers identified as Handala, an Iran-linked hacking group, whose logo appeared on the company's login pages, highlighting serious security vulnerabilities.
- System Restoration Priority: The company is now prioritizing the restoration of systems directly related to customer interactions, ordering, and shipping to quickly return to normal operations, ensuring that customer service remains unaffected, which underscores its commitment to client relationships.
- Employee Safety Measures: Stryker has advised its global workforce of 56,000 to immediately disconnect from all networks and refrain from using company-issued devices to prevent potential data breaches and further security risks, demonstrating a strong focus on data security for both employees and customers.
- Stock Price Volatility: Following the cybersecurity breach, Stryker's shares experienced a multi-day decline, reflecting market concerns regarding the company's cybersecurity defenses, which could impact future investor confidence and overall company valuation.
See More
- Market Performance Review: The S&P 500 fell 1.6% last week, marking its first three-week losing streak in nearly a year due to the spike in oil prices driven by the Iran war, highlighting the market's sensitivity to geopolitical risks.
- Oil Price Volatility Analysis: Brent and West Texas Intermediate crude oil surged over 11% and 8% respectively over the past five trading sessions, with Brent settling above $100 for the first time since 2022, reflecting heightened market concerns over supply disruptions.
- Investment Strategy Adjustment: During the market turmoil, Jim Cramer advised investors to remain on the sidelines to avoid completely exiting the stock market during uncertain times, which could lead to missing out on future rebounds, while also increasing Procter & Gamble shares on Wednesday, indicating confidence in consumer goods.
- Cybersecurity Investment Opportunity: CrowdStrike performed well in the portfolio with a 3% weekly gain, as the escalation of the Iran war raised the risk of cyberattacks, leading Jim Cramer to view the company as a high-quality stock worth investing in due to its leadership in cybersecurity.
See More
- Impact on Various Sectors: The ongoing war in Iran is expected to affect multiple sectors, including technology.
- Key Issues: Major concerns include the supply of raw materials, rising interest rates, and the potential for a cyberwar.
See More










